American CryoStem Corporation (CRYO)
$0.107
Rating:
Recommendation:
-
| Symbol | CRYO |
|---|---|
| Price | $0.107 |
| Beta | -0.704 |
| Volume Avg. | 0.02M |
| Market Cap | 4.738M |
| Shares () | - |
| 52 Week Range | 0.06-0.6 |
| 1y Target Est | - |
| DCF Unlevered | CRYO DCF -> | |
|---|---|---|
| DCF Levered | CRYO LDCF -> | |
| ROE | 219.23% | Strong Buy |
| ROA | -359.90% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | -156.40% | Sell |
| P/E | - | |
| P/B | -2.51 | Strong Sell |
About
Download (Excel)American CryoStem Corporation develops, markets, and licenses adipose tissue derived technologies for use in the fields of Regenerative and Personalized Medicine. The company's products include CELLECT collection, transportation, and storage system, which is a solution for physicians to collect and deliver tissue samples; ATGRAFT adipose tissue storage service, a fat collection, processing, and storage solution that enables physicians to provide their patients with tissue products and cell storage options; and ATCELL adipose derived stem cells. It also offers ACSelerat cell culture media products for growing human stromal cells. In addition, the company, provides contract manufacturing services for Autokine-CM, an anti-aging topical formulation; and autologous skin care product line. American CryoStem Corporation was founded in 1987 and is based in Eatontown, New Jersey.